IPM vs NBIX · rev $1.1M vs P/E 45, rev $2.36B
Intelligent Protection Management Corp (IPM) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Intelligent Protection Management Corp (IPM) is a software - application company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IPM revenue for 2024-12-31 was $1.1M. Net income was -$8.4M. Revenue was up 14.2% from 2023-12-31 to 2024-12-31. IPM currently screens at market cap $28.5M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IPM currently screens at market cap $28.5M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IPM and NBIX stock pages for the full models.
Not investment advice.